Strides Pharma divests majority stake in Pivot Path for Rs. 100 Cr
The deal marks Strides' latest move to monetise high-growth businesses while retaining exposure to their future upside
The deal marks Strides' latest move to monetise high-growth businesses while retaining exposure to their future upside
Subscribe To Our Newsletter & Stay Updated